Screening Performance Evaluation
Screening Performance Evaluation is a methodological framework used in pharmacophore validation that systematically assesses the effectiveness and reliability of a pharmacophore model in retrieving active compounds from large chemical libraries by quantifying metrics such as enrichment factors, receiver operating characteristic curves, and precision-recall outcomes.
342
Publications
26.1K
Citations
2K
Authors
693
Institutions
Publications per year
2017–2026
116
Parents
342
Statistical practice in high-throughput screening data analysis
Nathalie Malo, James A. Hanley, Sonia Cerquozzi et al. · Nature Biotechnology · 2006 · 726 citations
1–5 of 342
2K
12
h-index
7
h-index
7
h-index
6
h-index
6
h-index
1–5 of 2K
693
Queen Mary University of London
London, United Kingdom
13 h-index
46 publications
1.4K citations
Novartis (Switzerland)
Basel, Switzerland
10 h-index
38 publications
1.6K citations
University of California, San Francisco
San Francisco, United States
7 h-index
17 publications
658 citations
University of Bonn
Bonn, Germany
6 h-index
14 publications
430 citations

The University of Queensland
Brisbane, Australia
6 h-index
19 publications
655 citations
National Institutes of Health
Bethesda, United States
6 h-index
17 publications
891 citations
University College London
London, United Kingdom
6 h-index
24 publications
2.9K citations
Novartis (United States)
New York, United States
5 h-index
20 publications
1.6K citations
1–8 of 693
JCIM · 31 publications · 2.7K citations
24
h-index
25 publications · 8.1K citations
20
h-index
15 publications · 596 citations
13
h-index
9 publications · 279 citations
9
h-index
Repository · 9 publications · 259 citations
9
h-index
1–5